Symposier - Cardiovascular Problems with Lexiva (February 2010)

Links shared publicly online about this topic.

1,406
total visits

Symposier - Cardiovascular Problems with Lexiva (February 2010)

Uploaded and Shared in Youtube by: LawsuitGuru GlaxoSmithKline is notifying healthcare professionals that Lexiva (fosamprenavir calcium), a protease inhibitor, has been associated with an increased risk of myocardial infarction and dyslipidemia in HIV infected adults. The company's letter recommends that patients have their cholesterol and triglycerides tested prior to starting therapy with Lexiva and at periodic intervals during treatment with the drug. The letter also recommends treating

View full resource at symposier.com

Tags: STD, Mineral, Calcium, Drug, Healthcare, Lexiva, GlaxoSmithKline, Lawsuit

Most Recently Shared on February 4, 2010 at 9:31 pm By:

Symposier Cardiology

Cardiovascular Problems with Lexiva (fosamprenavir calcium, protease inhibitor) (February 2010) -- >http://ow.ly/13Zgr

2 years ago...

Retweet

Favorite

Symposier - Certain Powerheart/CardioVive/CardioLife AED Recalled (FDA April 2010)

symposier.com — “Uploaded and Shared in Youtube by: LawsuitGuru In February, Cardiac Science Corporation initiated a recall of several models of automated external defibrillators because manufacturing problems may make them susceptible to failure. If that happens, they might not be able to deliver therapy during a resuscitation attempt, and that could lead to serious adverse health consequences or death. The company says this action affects more than 12,000 AEDs manufactured or serviced between October 19, 2009 ” View full resource at symposier.com